With its acquisition by Perrigo in March 2005, Agis Industries begins a new chapter in its long history in the pharmaceutical industry in Israel and the world. Perrigo's acquisition of Agis Industries was completed on March 17, 2005. Subsequently, Agis Industries was renamed Perrigo Israel Pharmaceuticals Ltd. Agis Industries (1983) Ltd. was a developer of generic pharmaceuticals, active pharmaceutical ingredients, novel dermatological products, and consumer products. Perrigo Israel is headquartered in B'nei Brak, Israel, and has manufacturing facilities in Israel, Germany, and the United States. The Agis acquisition adds to Perrigo's strong business portfolio and global leadership in the health care field. Agis gives Perrigo: a platform for R&D and growth in generic pharmaceuticals an established position in active pharmaceutical ingredients an expanded store-brand OTC product portfolio an experienced management team The Perrigo Company (Nasdaq: PRGO) is the world's largest manufacturer of over-the-counter (OTC) pharmaceuticals and nutritional products for the store brand market. (Store brand products are sold by food, drug, mass merchandise, dollar store and club store retailers under their own labels.) The company also develops, manufactures, and markets prescription generic drugs, active pharmaceutical ingredients, consumer products, and operates manufacturing facilities in the United States, Israel, United Kingdom, Mexico, and Germany. Perrigo Company common stock is traded on the Nasdaq and on the Tel Aviv Stock Exchange (symbol: PRGO). Perrigo is headquartered in Allegan, Michigan. For detailed company and financial information, see Perrigo.